Evaluating Myelodysplastic Syndrome Risks in NET Patients Planned for Peptide Radionuclide Therapy
Clinical trial NCT06510868 · RECRUITING
Trial details
- NCT number
- NCT06510868
- Sponsor
- University Health Network, Toronto
- Status
- RECRUITING
- Study type
- OBSERVATIONAL
- Start date
- 2024-08-01
- Primary completion
- 2028-04-01
- Enrollment
- 45
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.